Neoadjuvant therapy in skin cancer: current evidence and future perspectives.

The development of immune checkpoint inhibitors and targeted therapies has fundamentally changed the treatment of cutaneous malignancies, especially in squamous cell carcinoma, melanoma, and Merkel cell carcinoma. The latest neoadjuvant approaches ha…

Preview only. Read the full abstract at the source